Inventor · disambiguated record
Aaron Keith Chamberlain
Also filed as: CHAMBERLAIN AARON · CHAMBERLAIN AARON K · CHAMBERLAIN AARON KEITH
19 granted patents·21 pending applications·877 citations·filing 2004–2025
96Inventor score
Top patents by PatentIndex Score
40 records- 0199US8802820B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2007·Granted Aug 12, 2014·83 cites·4 claims
- 0299US8367805B2Fc variants with altered binding to FcRnXENCOR INC·Filed 2008·Granted Feb 5, 2013·210 cites·3 claims
- 0399US8088376B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2011·Granted Jan 3, 2012·191 cites·1 claims
- 0498US10336818B2Fc variants with altered binding to FcRnXENCOR INC·Filed 2014·Granted Jul 2, 2019·47 cites·5 claims
- 0598US9803023B2Fc variants with altered binding to FcRnXENCOR INC·Filed 2015·Granted Oct 31, 2017·62 cites·9 claims
- 0698US8883973B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2010·Granted Nov 11, 2014·57 cites·20 claims
- 0798US8394925B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2011·Granted Mar 12, 2013·63 cites·4 claims
- 0897US12492253B1Anti-human C5 antibodiesXENCOR INC·Filed 2025·Granted Dec 9, 2025·1 cites·1 claims
- 0997US8338574B2FC variants with altered binding to FCRNCHAMBERLAIN AARON KEITH·Filed 2010·Granted Dec 25, 2012·32 cites·5 claims
- 1097US8324351B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2010·Granted Dec 4, 2012·30 cites·5 claims
- 1196US8318907B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2010·Granted Nov 27, 2012·27 cites·5 claims
- 1295US9200079B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2005·Granted Dec 1, 2015·28 cites·5 claims
- 1393US8852586B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2010·Granted Oct 7, 2014·12 cites·4 claims
- 1493US7557190B2Optimized proteins that target Ep-CAMXENCOR INC·Filed 2006·Granted Jul 7, 2009·28 cites·10 claims
- 1589US2025011440A1Fc VARIANTS WITH ALTERED BINDING TO FcRnXENCOR INC·Filed 2024·Application pending·0 cites
- 1686US2024327508A1Fc VARIANTS WITH ALTERED BINDING TO FcRnXENCOR INC·Filed 2024·Application pending·0 cites
- 1784US9856310B2UTI fusion proteinsTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jan 2, 2018·4 cites·8 claims
- 1880US12215165B2Fc variants with altered binding to FcRnXENCOR INC·Filed 2021·Granted Feb 4, 2025·0 cites·6 claims
- 1980US10351618B2UTI fusion proteinsTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jul 16, 2019·2 cites·16 claims
- 2079US2025230227A1Fc VARIANTS WITH ALTERED BINDING TO FcRnXENCOR INC·Filed 2025·Application pending·0 cites
- 2178US2022281964A1Fc VARIANTS WITH ALTERED BINDING TO FcRnXENCOR INC·Filed 2022·Application pending·0 cites
- 2276US11932685B2Fc variants with altered binding to FcRnXENCOR INC·Filed 2020·Granted Mar 19, 2024·0 cites·5 claims
- 2373US2021115147A1Fc VARIANTS WITH ALTERED BINDING TO FcRnXENCOR INC·Filed 2020·Application pending·0 cites
- 2471US2022127334A1Uti fusion proteinsTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 2569US2020255502A1Fc VARIANTS WITH ALTERED BINDING TO FcRnXENCOR INC·Filed 2019·Application pending·0 cites
- 2669US2020262899A1Fc VARIANTS WITH ALTERED BINDING TO FcRnXENCOR INC·Filed 2020·Application pending·0 cites
- 2769US2024239879A1Fc VARIANTS WITH ALTERED BINDING TO FcRnXENCOR INC·Filed 2024·Application pending·0 cites
- 2869US2021115118A1Fc VARIANTS WITH ALTERED BINDING TO FcRnXENCOR INC·Filed 2020·Application pending·0 cites
- 2968US2015099863A1Fc VARIANTS WITH ALTERED BINDING TO FcRnXENCOR INC·Filed 2014·Application pending·0 cites
- 3067US2015152183A1Fc VARIANTS WITH ALTERED BINDING TO FcRnXENCOR INC·Filed 2014·Application pending·0 cites
- 3166US11198739B2Fc variants with altered binding to FcRnXENCOR INC·Filed 2017·Granted Dec 14, 2021·0 cites·4 claims
- 3264US2018162946A1Fc VARIANTS WITH ALTERED BINDING TO FcRnXENCOR INC·Filed 2017·Application pending·0 cites
- 3360US2020040062A1Uti fusion proteinsTAKEDA PHARMACEUTICALS CO·Filed 2019·Application pending·0 cites
- 3456US2005181994A1Novel variants of CD40L proteinXENCOR INC·Filed 2004·Application pending·0 cites
- 3550US2008152649A1Optimized igf-1r antibodies and methods of using the sameXENCOR INC·Filed 2008·Application pending·0 cites
- 3650US2006003412A1Protein engineering with analogous contact environmentsXENCOR INC·Filed 2005·Application pending·0 cites
- 3745US2007135620A1Fc variants with altered binding to FcRnXENCOR INC·Filed 2006·Application pending·0 cites
- 3844US2006074225A1Monomeric immunoglobulin Fc domainsXENCOR INC·Filed 2005·Application pending·0 cites
- 3939US2010311954A1Optimized Proteins that Target Ep-CAMXENCOR INC·Filed 2010·Application pending·0 cites
- 4038US2019358508A1Moment of inertia ball bat structure fitting deviceCHAMBERLAIN AARON·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aaron Keith Chamberlain files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →